View in EDS HTML Full Text PDF Full Text

Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer.

Saved in:

Bibliographic Details
Title:	Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer.
Authors:	Can, Süleyman¹ (AUTHOR), Çakıcı, Veli^1,2 (AUTHOR), Kahveci, Gizem Bakır^1,2 (AUTHOR), Eroğlu, Şeyma^1,2 (AUTHOR), Tok, Burak¹ (AUTHOR), Uygun, Gökhan¹ (AUTHOR), Özer, Esra¹ (AUTHOR), Çırak, Yalçın¹ (AUTHOR), Gökmen, İvo¹ (AUTHOR) ivo_georgiev1@hotmail.com
Source:	Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 7, p2805. 17p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20770383
DOI:	10.3390/jcm15072805